Heartbeam, Inc. (BEAT) financial statements (2022 and earlier)
Company profile
| Business Address |
2118 WALSH AVE., SUITE 210 SANTA CLARA, CA 95050 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| SIC | 3841 - Surgical and Medical Instruments and Apparatus (benchmarking) |
| More info | Complete financial analysis Financial benchmarking |
Balance sheet (Statement of financial position) ($ in thousands)
| 12/31/2021 Q4 | 9/30/2021 Q3 | |||
|---|---|---|---|---|
| ASSETS | ||||
| Current Assets | ||||
| Cash, cash equivalents, and short-term investments | 13,192 | 795 | ||
| Cash and cash equivalents | 13,192 | 795 | ||
| Total current assets: | 13,192 | 795 | ||
| Noncurrent Assets | ||||
| Other undisclosed assets | 806 | 166 | ||
| TOTAL ASSETS: | 13,998 | 961 | ||
| LIABILITIES AND EQUITY | ||||
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities, including: | 588 | 699 | ||
| Other undisclosed accounts payable and accrued liabilities | 588 | 699 | ||
| Debt | 5,419 | |||
| Other liabilities | 30 | |||
| Total current liabilities: | 588 | 6,148 | ||
| Noncurrent Liabilities | ||||
| Total liabilities: | 588 | 6,148 | ||
| Stockholders' equity | ||||
| Stockholders' equity attributable to parent | 13,410 | (5,187) | ||
| Common stock | 1 | |||
| Additional paid in capital | 22,633 | 1,952 | ||
| Accumulated deficit | (9,224) | (7,139) | ||
| Total stockholders' equity: | 13,410 | (5,187) | ||
| TOTAL LIABILITIES AND EQUITY: | 13,998 | 961 | ||
Income statement (P&L) ($ in thousands)
| 12/31/2021 Q4 | 9/30/2021 Q3 | ||
|---|---|---|---|
| Operating expenses | (1,341) | (446) | |
| Operating loss: | (1,341) | (446) | |
| Nonoperating expense | (2,165) | ||
| Interest and debt expense | (744) | (742) | |
| Loss from continuing operations before equity method investments, income taxes: | (4,250) | (1,188) | |
| Other undisclosed income from continuing operations before income taxes | 2,165 | ||
| Net loss available to common stockholders, diluted: | (2,085) | (1,188) | |
Comprehensive Income ($ in thousands)
| 12/31/2021 Q4 | 9/30/2021 Q3 | ||
|---|---|---|---|
| Net loss: | (2,085) | (1,188) | |
| Comprehensive loss, net of tax, attributable to parent: | (2,085) | (1,188) | |
Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.